世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州の遠隔患者モニタリング・ケア市場-2030年までの産業動向と予測


Europe Remote Patient Monitoring and Care Market - Industry Trends and Forecast to 2030

欧州の遠隔患者モニタリング・ケア市場は、2022年の23億3,495万米ドルから2030年には62億5,862万米ドルに達し、2023年から2030年の予測期間中に年平均成長率14.2％で成長すると予測されている。 市場区分 欧... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Data Bridge Market Research
データブリッジマーケットリサーチ 		2023年5月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		193 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

欧州の遠隔患者モニタリング・ケア市場は、2022年の23億3,495万米ドルから2030年には62億5,862万米ドルに達し、2023年から2030年の予測期間中に年平均成長率14.2％で成長すると予測されている。

市場区分
欧州の遠隔患者モニタリング・ケア市場：デバイスタイプ別（心臓モニタリングデバイス、血圧モニタリングデバイス、血糖モニタリングデバイス、呼吸器モニタリングデバイス、神経モニタリングデバイス、マルチパラメータモニタリングデバイス、その他）、用途別（腫瘍学、糖尿病、心血管疾患、その他）、エンドユーザー別（病院ベース患者、外来患者、在宅医療患者）、国別（ドイツ、フランス、英国、イタリア、スペイン、ベルギー、トルコ、オランダ、ロシア、スイス、その他欧州）-産業動向と2030年までの予測


欧州アカウントの遠隔患者モニタリングとケア市場ダイナミクスの概要

促進要因
- 慢性疾患の増加

抑制要因

- 厳しい規制の枠組み

機会

- 市場プレーヤーによる戦略的イニシアティブ

市場プレーヤー

欧州の遠隔患者モニタリング・ケア市場で事業を展開する主な市場プレイヤーを以下に挙げる：
- メドトロニック
- ボストン・サイエンティフィック社
- バイタルコネクト
- バイオビート
- ゼネラル・エレクトリック
- フィリップスN.V.
- オムロン株式会社
- アボット
- 日本光電工業株式会社
- ビビファイヘルス株式会社
- アエロテル・メディカル・システムズ
- BIOTRONIK SE & Co.KG
- エー・アンド・デイ株式会社
- アライブコア社
- マシモ
- デックスコム社
- センスオニクス社
- レスメッド
- 100プラス
- クロニセンスメディカル
- ヴィトルス
- カルディオモ
- コーチケア
- ネティエラ
- ウィジングス


ページTOPに戻る


目次

TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTER’S FIVE FORCES 47
4.2 VALUE CHAIN ANALYSIS: 48
4.3 COMPETITIVE ANALYSIS 49
4.4 BRAND ANALYSIS 51
4.5 ECOSYSTEM MAPS 52
4.6 TECHNOLOGICAL TRENDS 53
4.7 TOP WINNING STRATEGIES 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 57
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 57
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 59
5.1.4 INCREASING GOVERNMENT INITIATIVES 59
5.2 RESTRAINTS 60
5.2.1 STRICT REGULATORY FRAMEWORK 60
5.2.2 LACK OF STANDARDIZATION 61
5.3 OPPORTUNITIES 61
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 62
5.4 CHALLENGES 63
5.4.1 LACK OF SKILLED PROFESSIONALS 63
5.4.2 RISK TO PATIENT'S DATA SECURITY 63
6 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 65
6.1 OVERVIEW 66
6.2 CARDIAC MONITORING DEVICES 69
6.3 BLOOD PRESSURE MONITORING DEVICES 70
6.4 MULTI-PARAMETER MONITORING DEVICES 71
6.5 BLOOD GLUCOSE MONITORING DEVICES 72
6.6 RESPIRATORY MONITORING DEVICES 73
6.7 NEUROLOGICAL MONITORING DEVICES 74
6.8 OTHERS 75
7 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 76
7.1 OVERVIEW 77
7.2 CARDIOVASCULAR DISEASE 80
7.2.1 CORONARY HEART DISEASE 81
7.2.2 STROKE 81
7.2.3 PERIPHERAL ARTERIAL DISEASE 81
7.2.4 AORTIC DISEASE 81
7.2.5 OTHERS 81
7.3 DIABETES 81
7.4 ONCOLOGY 82
7.5 OTHERS 83
8 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 84
8.1 OVERVIEW 85
8.2 HOME HEALTHCARE PATIENTS 88
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 89
8.2.2 CARDIAC MONITORING DEVICES 89
8.2.3 BLOOD PRESSURE MONITORING DEVICES 89
8.2.4 MULTI-PARAMETER MONITORING DEVICES 89
8.2.5 RESPIRATORY MONITORING DEVICES 89
8.2.6 NEUROLOGICAL MONITORING DEVICES 89
8.2.7 OTHERS 90
8.3 AMBULATORY PATIENTS 90
8.3.1 MULTI-PARAMETER MONITORING DEVICES 91
8.3.2 RESPIRATORY MONITORING DEVICES 91
8.3.3 CARDIAC MONITORING DEVICES 91
8.3.4 BLOOD PRESSURE MONITORING DEVICES 91
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 91
8.3.6 NEUROLOGICAL MONITORING DEVICES 91
8.3.7 OTHERS 92
8.4 HOSPITAL-BASED PATIENTS 92
8.4.1 MULTI-PARAMETER MONITORING DEVICES 93
8.4.2 CARDIAC MONITORING DEVICES 93
8.4.3 RESPIRATORY MONITORING DEVICES 93
8.4.4 BLOOD PRESSURE MONITORING DEVICES 93
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 93
8.4.6 NEUROLOGICAL MONITORING DEVICES 93
8.4.7 OTHERS 94
9 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 95
9.1 EUROPE 96
9.1.1 GERMANY 105
9.1.2 U.K. 109
9.1.3 FRANCE 113
9.1.4 ITALY 117
9.1.5 RUSSIA 121
9.1.6 SPAIN 125
9.1.7 TURKEY 129
9.1.8 SWITZERLAND 133
9.1.9 NETHERLANDS 137
9.1.10 BELGIUM 141
9.1.11 REST OF EUROPE 145
10 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 146
10.1 COMPANY SHARE ANALYSIS: EUROPE 146
11 SWOT ANALYSIS 147
12 COMPANY PROFILE 148
12.1 MEDTRONIC 148
12.1.1 COMPANY SNAPSHOT 148
12.1.2 REVENUE ANALYSIS 149
12.1.3 COMPANY SHARE ANALYSIS 149
12.1.4 PRODUCT PORTFOLIO 150
12.1.5 RECENT DEVELOPMENT 150
12.2 DEXCOM, INC. 151
12.2.1 COMPANY SNAPSHOT 151
12.2.2 REVENUE ANALYSIS 151
12.2.3 COMPANY SHARE ANALYSIS 152
12.2.4 PRODUCT PORTFOLIO 152
12.2.5 RECENT DEVELOPMENT 152
12.3 ABBOTT 153
12.3.1 COMPANY SNAPSHOT 153
12.3.2 REVENUE ANALYSIS 153
12.3.3 COMPANY SHARE ANALYSIS 154
12.3.4 PRODUCT PORTFOLIO 154
12.3.5 RECENT DEVELOPMENT 154
12.4 RESMED 155
12.4.1 COMPANY SNAPSHOT 155
12.4.2 REVENUE ANALYSIS 155
12.4.3 COMPANY SHARE ANALYSIS 156
12.4.4 PRODUCT PORTFOLIO 156
12.4.5 RECENT DEVELOPMENT 156
12.5 BIOTRONIK SE & CO. KG 157
12.5.1 COMPANY SNAPSHOT 157
12.5.2 COMPANY SHARE ANALYSIS 157
12.5.3 PRODUCT PORTFOLIO 158
12.5.4 RECENT DEVELOPMENT 158
12.6 100 PLUS. 159
12.6.1 COMPANY SNAPSHOT 159
12.6.2 PRODUCT PORTFOLIO 159
12.6.3 RECENT DEVELOPMENTS 159
12.7 A&D COMPANY, LIMITED 160
12.7.1 COMPANY SNAPSHOT 160
12.7.2 REVENUE ANALYSIS 160
12.7.3 COMPANY SHARE ANALYSIS 161
12.7.4 PRODUCT PORTFOLIO 161
12.7.5 RECENT DEVELOPMENT 161
12.8 AEROTEL MEDICAL SYSTEMS 162
12.8.1 COMPANY SNAPSHOT 162
12.8.2 PRODUCT PORTFOLIO 162
12.8.3 RECENT DEVELOPMENT 162
12.9 ALIVECOR, INC. 163
12.9.1 COMPANY SNAPSHOT 163
12.9.2 COMPANY SHARE ANALYSIS 163
12.9.3 PRODUCT PORTFOLIO 163
12.9.4 RECENT DEVELOPMENTS 164
12.10 BIOBEAT 165
12.10.1 COMPANY SNAPSHOT 165
12.10.2 PRODUCT PORTFOLIO 165
12.10.3 RECENT DEVELOPMENT 165
12.11 BOSTON SCIENTIFIC CORPORATION 166
12.11.1 COMPANY SNAPSHOT 166
12.11.2 REVENUE ANALYSIS 167
12.11.3 COMPANY SHARE ANALYSIS 167
12.11.4 PRODUCT PORTFOLIO 167
12.11.5 RECENT DEVELOPMENT 168
12.12 CARDIOMO 169
12.12.1 COMPANY SNAPSHOT 169
12.12.2 PRODUCT PORTFOLIO 169
12.12.3 RECENT DEVELOPMENTS 169
12.13 CHRONISENSE MEDICAL, LTD. 170
12.13.1 COMPANY SNAPSHOT 170
12.13.2 PRODUCT PORTFOLIO 170
12.13.3 RECENT DEVELOPMENT 170
12.14 COACHCARE 171
12.14.1 COMPANY SNAPSHOT 171
12.14.2 PRODUCT PORTFOLIO 171
12.14.3 RECENT DEVELOPMENT 171
12.15 GENERAL ELECTRIC 172
12.15.1 COMPANY SNAPSHOT 172
12.15.2 REVENUE ANALYSIS 172
12.15.3 COMPANY SHARE ANALYSIS 173
12.15.4 PRODUCT PORTFOLIO 173
12.15.5 RECENT DEVELOPMENT 173
12.16 KONINKLIJKE PHILIPS N.V. 174
12.16.1 COMPANY SNAPSHOT 174
12.16.2 REVENUE ANALYSIS 174
12.16.3 COMPANY SHARE ANALYSIS 175
12.16.4 PRODUCT PORTFOLIO 175
12.16.5 RECENT DEVELOPMENT 175
12.17 MASIMO 176
12.17.1 COMPANY SNAPSHOT 176
12.17.2 REVENUE ANALYSIS 176
12.17.3 COMPANY SHARE ANALYSIS 177
12.17.4 PRODUCT PORTFOLIO 177
12.17.5 RECENT DEVELOPMENT 177
12.18 NETEERA 178
12.18.1 COMPANY SNAPSHOT 178
12.18.2 PRODUCT PORTFOLIO 178
12.18.3 RECENT DEVELOPMENT 178
12.19 NIHON KOHDEN CORPORATION 179
12.19.1 COMPANY SNAPSHOT 179
12.19.2 REVENUE ANALYSIS 179
12.19.3 COMPANY SHARE ANALYSIS 180
12.19.4 PRODUCT PORTFOLIO 180
12.19.5 RECENT DEVELOPMENT 180
12.20 OMRON CORPORATION 181
12.20.1 COMPANY SNAPSHOT 181
12.20.2 REVENUE ANALYSIS 181
12.20.3 COMPANY SHARE ANALYSIS 182
12.20.4 PRODUCT PORTFOLIO 182
12.20.5 RECENT DEVELOPMENT 182
12.21 SENSEONICS, INC. 183
12.21.1 COMPANY SNAPSHOT 183
12.21.2 REVENUE ANALYSIS 183
12.21.3 COMPANY SHARE ANALYSIS 184
12.21.4 PRODUCT PORTFOLIO 184
12.21.5 RECENT DEVELOPMENT 184
12.22 VITALCONNECT 185
12.22.1 COMPANY SNAPSHOT 185
12.22.2 PRODUCT PORTFOLIO 185
12.22.3 RECENT DEVELOPMENT 185
12.23 VITLS 186
12.23.1 COMPANY SNAPSHOT 186
12.23.2 PRODUCT PORTFOLIO 186
12.23.3 RECENT DEVELOPMENT 186
12.24 VIVIFY HEALTH INC. 187
12.24.1 COMPANY SNAPSHOT 187
12.24.2 PRODUCT PORTFOLIO 187
12.24.3 RECENT DEVELOPMENTS 187
12.25 WITHINGS 188
12.25.1 COMPANY SNAPSHOT 188
12.25.2 COMPANY SHARE ANALYSIS 188
12.25.3 PRODUCT PORTFOLIO 188
12.25.4 RECENT DEVELOPMENT 189
13 QUESTIONNAIRE 190
14 RELATED REPORTS 193

　

ページTOPに戻る


　

Summary

The Europe remote patient monitoring and care market is expected to reach USD 6,258.62 million by 2030 from USD 2,334.95 million in 2022, growing at a CAGR of 14.2% during the forecast period of 2023 to 2030.

Market Segmentation
Europe Remote Patient Monitoring and Care Market, By Device Type (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Respiratory Monitoring Devices, Neurological Monitoring Devices, Multi-Parameter Monitoring Devices, and Others), Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), End User (Hospital Based Patients, Ambulatory Patients, and Home Healthcare Patients), Country (Germany, France, U.K., Italy, Spain, Belgium, Turkey, Netherlands, Russia, Switzerland, and Rest of Europe) - Industry Trends and Forecast to 2030


Overview of Europe Accounts Remote Patient Monitoring and Care Market Dynamics

Driver
• Increasing prevalence of chronic diseases

Restraint

• Stringent regulatory framework

Opportunity

• Strategic initiatives by market players

Market Players:

Some of the major market players operating in the Europe remote patient monitoring and care market are:
• Medtronic
• Boston Scientific Corporation
• VitalConnect
• Biobeat
• General Electric
• Koninklijke Philips N.V.
• OMRON Corporation
• Abbott
• Nihon Kohden Corporation
• Vivify Health, Inc.
• Aerotel Medical Systems
• BIOTRONIK SE & Co. KG
• A&D Company, Limited
• AliveCor, Inc.
• Masimo
• Dexcom, Inc.
• Senseonics, Inc.
• ResMed
• 100Plus.
• ChroniSense Medical, Ltd.
• Vitls
• Cardiomo
• CoachCare
• neteera
• Withings



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTER’S FIVE FORCES 47
4.2 VALUE CHAIN ANALYSIS: 48
4.3 COMPETITIVE ANALYSIS 49
4.4 BRAND ANALYSIS 51
4.5 ECOSYSTEM MAPS 52
4.6 TECHNOLOGICAL TRENDS 53
4.7 TOP WINNING STRATEGIES 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 57
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 57
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 59
5.1.4 INCREASING GOVERNMENT INITIATIVES 59
5.2 RESTRAINTS 60
5.2.1 STRICT REGULATORY FRAMEWORK 60
5.2.2 LACK OF STANDARDIZATION 61
5.3 OPPORTUNITIES 61
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 62
5.4 CHALLENGES 63
5.4.1 LACK OF SKILLED PROFESSIONALS 63
5.4.2 RISK TO PATIENT'S DATA SECURITY 63
6 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 65
6.1 OVERVIEW 66
6.2 CARDIAC MONITORING DEVICES 69
6.3 BLOOD PRESSURE MONITORING DEVICES 70
6.4 MULTI-PARAMETER MONITORING DEVICES 71
6.5 BLOOD GLUCOSE MONITORING DEVICES 72
6.6 RESPIRATORY MONITORING DEVICES 73
6.7 NEUROLOGICAL MONITORING DEVICES 74
6.8 OTHERS 75
7 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 76
7.1 OVERVIEW 77
7.2 CARDIOVASCULAR DISEASE 80
7.2.1 CORONARY HEART DISEASE 81
7.2.2 STROKE 81
7.2.3 PERIPHERAL ARTERIAL DISEASE 81
7.2.4 AORTIC DISEASE 81
7.2.5 OTHERS 81
7.3 DIABETES 81
7.4 ONCOLOGY 82
7.5 OTHERS 83
8 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 84
8.1 OVERVIEW 85
8.2 HOME HEALTHCARE PATIENTS 88
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 89
8.2.2 CARDIAC MONITORING DEVICES 89
8.2.3 BLOOD PRESSURE MONITORING DEVICES 89
8.2.4 MULTI-PARAMETER MONITORING DEVICES 89
8.2.5 RESPIRATORY MONITORING DEVICES 89
8.2.6 NEUROLOGICAL MONITORING DEVICES 89
8.2.7 OTHERS 90
8.3 AMBULATORY PATIENTS 90
8.3.1 MULTI-PARAMETER MONITORING DEVICES 91
8.3.2 RESPIRATORY MONITORING DEVICES 91
8.3.3 CARDIAC MONITORING DEVICES 91
8.3.4 BLOOD PRESSURE MONITORING DEVICES 91
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 91
8.3.6 NEUROLOGICAL MONITORING DEVICES 91
8.3.7 OTHERS 92
8.4 HOSPITAL-BASED PATIENTS 92
8.4.1 MULTI-PARAMETER MONITORING DEVICES 93
8.4.2 CARDIAC MONITORING DEVICES 93
8.4.3 RESPIRATORY MONITORING DEVICES 93
8.4.4 BLOOD PRESSURE MONITORING DEVICES 93
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 93
8.4.6 NEUROLOGICAL MONITORING DEVICES 93
8.4.7 OTHERS 94
9 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 95
9.1 EUROPE 96
9.1.1 GERMANY 105
9.1.2 U.K. 109
9.1.3 FRANCE 113
9.1.4 ITALY 117
9.1.5 RUSSIA 121
9.1.6 SPAIN 125
9.1.7 TURKEY 129
9.1.8 SWITZERLAND 133
9.1.9 NETHERLANDS 137
9.1.10 BELGIUM 141
9.1.11 REST OF EUROPE 145
10 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 146
10.1 COMPANY SHARE ANALYSIS: EUROPE 146
11 SWOT ANALYSIS 147
12 COMPANY PROFILE 148
12.1 MEDTRONIC 148
12.1.1 COMPANY SNAPSHOT 148
12.1.2 REVENUE ANALYSIS 149
12.1.3 COMPANY SHARE ANALYSIS 149
12.1.4 PRODUCT PORTFOLIO 150
12.1.5 RECENT DEVELOPMENT 150
12.2 DEXCOM, INC. 151
12.2.1 COMPANY SNAPSHOT 151
12.2.2 REVENUE ANALYSIS 151
12.2.3 COMPANY SHARE ANALYSIS 152
12.2.4 PRODUCT PORTFOLIO 152
12.2.5 RECENT DEVELOPMENT 152
12.3 ABBOTT 153
12.3.1 COMPANY SNAPSHOT 153
12.3.2 REVENUE ANALYSIS 153
12.3.3 COMPANY SHARE ANALYSIS 154
12.3.4 PRODUCT PORTFOLIO 154
12.3.5 RECENT DEVELOPMENT 154
12.4 RESMED 155
12.4.1 COMPANY SNAPSHOT 155
12.4.2 REVENUE ANALYSIS 155
12.4.3 COMPANY SHARE ANALYSIS 156
12.4.4 PRODUCT PORTFOLIO 156
12.4.5 RECENT DEVELOPMENT 156
12.5 BIOTRONIK SE & CO. KG 157
12.5.1 COMPANY SNAPSHOT 157
12.5.2 COMPANY SHARE ANALYSIS 157
12.5.3 PRODUCT PORTFOLIO 158
12.5.4 RECENT DEVELOPMENT 158
12.6 100 PLUS. 159
12.6.1 COMPANY SNAPSHOT 159
12.6.2 PRODUCT PORTFOLIO 159
12.6.3 RECENT DEVELOPMENTS 159
12.7 A&D COMPANY, LIMITED 160
12.7.1 COMPANY SNAPSHOT 160
12.7.2 REVENUE ANALYSIS 160
12.7.3 COMPANY SHARE ANALYSIS 161
12.7.4 PRODUCT PORTFOLIO 161
12.7.5 RECENT DEVELOPMENT 161
12.8 AEROTEL MEDICAL SYSTEMS 162
12.8.1 COMPANY SNAPSHOT 162
12.8.2 PRODUCT PORTFOLIO 162
12.8.3 RECENT DEVELOPMENT 162
12.9 ALIVECOR, INC. 163
12.9.1 COMPANY SNAPSHOT 163
12.9.2 COMPANY SHARE ANALYSIS 163
12.9.3 PRODUCT PORTFOLIO 163
12.9.4 RECENT DEVELOPMENTS 164
12.10 BIOBEAT 165
12.10.1 COMPANY SNAPSHOT 165
12.10.2 PRODUCT PORTFOLIO 165
12.10.3 RECENT DEVELOPMENT 165
12.11 BOSTON SCIENTIFIC CORPORATION 166
12.11.1 COMPANY SNAPSHOT 166
12.11.2 REVENUE ANALYSIS 167
12.11.3 COMPANY SHARE ANALYSIS 167
12.11.4 PRODUCT PORTFOLIO 167
12.11.5 RECENT DEVELOPMENT 168
12.12 CARDIOMO 169
12.12.1 COMPANY SNAPSHOT 169
12.12.2 PRODUCT PORTFOLIO 169
12.12.3 RECENT DEVELOPMENTS 169
12.13 CHRONISENSE MEDICAL, LTD. 170
12.13.1 COMPANY SNAPSHOT 170
12.13.2 PRODUCT PORTFOLIO 170
12.13.3 RECENT DEVELOPMENT 170
12.14 COACHCARE 171
12.14.1 COMPANY SNAPSHOT 171
12.14.2 PRODUCT PORTFOLIO 171
12.14.3 RECENT DEVELOPMENT 171
12.15 GENERAL ELECTRIC 172
12.15.1 COMPANY SNAPSHOT 172
12.15.2 REVENUE ANALYSIS 172
12.15.3 COMPANY SHARE ANALYSIS 173
12.15.4 PRODUCT PORTFOLIO 173
12.15.5 RECENT DEVELOPMENT 173
12.16 KONINKLIJKE PHILIPS N.V. 174
12.16.1 COMPANY SNAPSHOT 174
12.16.2 REVENUE ANALYSIS 174
12.16.3 COMPANY SHARE ANALYSIS 175
12.16.4 PRODUCT PORTFOLIO 175
12.16.5 RECENT DEVELOPMENT 175
12.17 MASIMO 176
12.17.1 COMPANY SNAPSHOT 176
12.17.2 REVENUE ANALYSIS 176
12.17.3 COMPANY SHARE ANALYSIS 177
12.17.4 PRODUCT PORTFOLIO 177
12.17.5 RECENT DEVELOPMENT 177
12.18 NETEERA 178
12.18.1 COMPANY SNAPSHOT 178
12.18.2 PRODUCT PORTFOLIO 178
12.18.3 RECENT DEVELOPMENT 178
12.19 NIHON KOHDEN CORPORATION 179
12.19.1 COMPANY SNAPSHOT 179
12.19.2 REVENUE ANALYSIS 179
12.19.3 COMPANY SHARE ANALYSIS 180
12.19.4 PRODUCT PORTFOLIO 180
12.19.5 RECENT DEVELOPMENT 180
12.20 OMRON CORPORATION 181
12.20.1 COMPANY SNAPSHOT 181
12.20.2 REVENUE ANALYSIS 181
12.20.3 COMPANY SHARE ANALYSIS 182
12.20.4 PRODUCT PORTFOLIO 182
12.20.5 RECENT DEVELOPMENT 182
12.21 SENSEONICS, INC. 183
12.21.1 COMPANY SNAPSHOT 183
12.21.2 REVENUE ANALYSIS 183
12.21.3 COMPANY SHARE ANALYSIS 184
12.21.4 PRODUCT PORTFOLIO 184
12.21.5 RECENT DEVELOPMENT 184
12.22 VITALCONNECT 185
12.22.1 COMPANY SNAPSHOT 185
12.22.2 PRODUCT PORTFOLIO 185
12.22.3 RECENT DEVELOPMENT 185
12.23 VITLS 186
12.23.1 COMPANY SNAPSHOT 186
12.23.2 PRODUCT PORTFOLIO 186
12.23.3 RECENT DEVELOPMENT 186
12.24 VIVIFY HEALTH INC. 187
12.24.1 COMPANY SNAPSHOT 187
12.24.2 PRODUCT PORTFOLIO 187
12.24.3 RECENT DEVELOPMENTS 187
12.25 WITHINGS 188
12.25.1 COMPANY SNAPSHOT 188
12.25.2 COMPANY SHARE ANALYSIS 188
12.25.3 PRODUCT PORTFOLIO 188
12.25.4 RECENT DEVELOPMENT 189
13 QUESTIONNAIRE 190
14 RELATED REPORTS 193

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

Data Bridge Market Research社の医療デバイス分野での最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート


よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.